Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

Clinical trial NCT01431196 · COMPLETED

Trial details

NCT number: NCT01431196
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II Breast Cancer Stage III Breast Cancer

Start date: 2011-02-01
Primary completion: 2012-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.